GeneDx (NASDAQ:WGS) Upgraded by Jefferies Financial Group to “Buy” Rating
GeneDx (NASDAQ:WGS – Get Free Report) was upgraded by research analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a research report issued on Friday, Marketbeat Ratings reports. The firm presently has a $80.00 target price on the stock. Jefferies Financial Group’s target price would suggest a potential upside of […]
GeneDx (NASDAQ:WGS – Get Free Report) was upgraded by research analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a research report issued on Friday, Marketbeat Ratings reports. The firm presently has a $80.00 target price on the stock. Jefferies Financial Group’s target price would suggest a potential upside of […]
